NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

hyperopia, not sure what you wrote about - there is no guidance on the substance of their service agreement with Advent but they certainly did give guidance on the Sawston buildout plan in the August PR which gave a mid-October projected completion date for 'phase 1', though there is no info given on what will remain to be done after phase 1 to enable starting commercial mfg.

A cornerstone of this expanding program is completion of the Phase I buildout of the Sawston, UK manufacturing facility.

With construction crews working double shifts to accelerate this completion, the Company currently anticipates the Phase I buildout will finish by mid-October of 2020.

This buildout is the culmination of several years of design, development and preparatory activities, including clean room suites, quarantined storage, quality control testing suites, controlled cryostorage (freezing) facilities for the finished products, as well as specialized systems (for example, for full air changes every 60 seconds in the clean room suites, and precise monitoring of particle counts in the clean room air).